Rahul K Arora
Overview
Explore the profile of Rahul K Arora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Donnici C, Ilincic N, Cao C, Zhang C, Deveaux G, Clifton D, et al.
Epidemics
. 2022 Oct;
41:100645.
PMID: 36308993
Seroprevalence studies have been used throughout the COVID-19 pandemic to monitor infection and immunity. These studies are often reported in peer-reviewed journals, but the academic writing and publishing process can...
12.
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report
Cable J, Fauci A, Dowling W, Gunther S, Bente D, Yadav P, et al.
Ann N Y Acad Sci
. 2022 Oct;
1518(1):209-225.
PMID: 36183296
The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10-13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium...
13.
Lewis H, Ware H, Whelan M, Subissi L, Li Z, Ma X, et al.
BMJ Glob Health
. 2022 Aug;
7(8).
PMID: 35998978
Introduction: Estimating COVID-19 cumulative incidence in Africa remains problematic due to challenges in contact tracing, routine surveillance systems and laboratory testing capacities and strategies. We undertook a meta-analysis of population-based...
14.
15.
Duarte N, Yanes-Lane M, Arora R, Bobrovitz N, Liu M, Bego M, et al.
Open Forum Infect Dis
. 2022 Feb;
9(2):ofab632.
PMID: 35103246
Population-level immune surveillance, which includes monitoring exposure and assessing vaccine-induced immunity, is a crucial component of public health decision-making during a pandemic. Serosurveys estimating the prevalence of severe acute respiratory...
16.
17.
18.
Arora R, Joseph A, Van Wyk J, Rocco S, Atmaja A, May E, et al.
Lancet Infect Dis
. 2020 Aug;
21(4):e75-e76.
PMID: 32763195
No abstract available.
19.
Arora R, Gibson A, Bebb D, Cheung W
Am J Clin Oncol
. 2020 Apr;
43(7):496-503.
PMID: 32349021
Objectives: The value of adjuvant chemotherapy in T2N0M0 non-small-cell lung cancer (NSCLC) is unclear. Some current guidelines suggest adjuvant chemotherapy be considered for patients with tumors ≥4 cm. Prior population-based...